Check out our latest news and press releases.
Bright Path applauds the team at Khona Scientific on achieving an important milestone in advancing domestic pharmaceutical manufacturing. Khona Scientific’s investment in expanding U.S.-based Key Starting Material (KSM) manufacturing represents a significant step toward strengthening...
Khona Scientific, a pioneer of advanced biomanufacturing solutions for complex natural product compounds, today revealed plans to deploy its modular biotechnology platform for production of key starting materials (KSMs) and active pharmaceutical ingredients (APIs) using...
Khona Scientific Inc., a synthetic biology company advancing biomanufacturing for pharmaceutical key starting materials, is excited to announce the appointment of Michael A. Gonzalez, PhD, to its Board of Directors. Dr. Gonzalez is Chief Scientific...
Khona Scientific Inc. is pleased to announce that it has been accepted into the Biopharmaceutical Manufacturing Preparedness (BioMaP) Consortium, a BARDA-supported public-private partnership focused on strengthening U.S. biopharmaceutical manufacturing preparedness. BioMaP’s stated purview includes expanding...
Benuvia Operations, LLC (“Benuvia”), a U.S.-based pharmaceutical development and manufacturing company specializing in regulated and controlled-substance active pharmaceutical ingredients (APIs), today announced the signing of a Letter of Intent (LOI) with Khona Scientific Inc. (“Khona”),...
Khona Scientific Inc., a synthetic biotechnology company and leader in the biosynthetic production of complex compounds, is excited to announce the acquisition of new and expanded laboratory space at Hatchlabs@Wilderness Place in Boulder, Colorado. This...
